Panobacumab Uses, Dosage, Side Effects and more
Panobacumab is under investigation in clinical trial NCT00851435 (Safety and Pharmacokinetics of KBPA-101 in Hospital Acquired Pneumonia Caused by O11 Pseudomonas Aeruginosa).
| Attribute | Details |
|---|---|
| Trade Name | Panobacumab |
| Generic | Panobacumab |
| Panobacumab Other Names | Panobacumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
